Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

MHRA issues recall alert for Abstral 200 microgram tablets

The Medicines and Health products Regulatory Agency (MHRA) has issued a class two medicines recall for Abstral 200 microgram sublingual tablets.

Batch NumberExpiry DatePack Size First Distributed
60877730231 July 202130 Tablets24 December 2019

Kyowa Kirin Limited is recalling the tablets batch as a precautionary measure, due to the reports of double tablets in a single blister pocket.


This was identified during reference sample inspection and there is a potential low risk of accidental double dosage.

The pharmacists have been adviced to stop supplying the batch immediately and quarantine all remaining stock and return it to their supplier.